Replies to post #819271 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

In my opinion report is neutral at the very best, but leaning negative , with $1 SP target , UK commercialization in late 27 and FDA in 2029. Not sure how is that supposed to help support SP in near to mid term .